Junyu Xu

674 total citations
21 papers, 345 citations indexed

About

Junyu Xu is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Junyu Xu has authored 21 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Junyu Xu's work include Catalytic C–H Functionalization Methods (7 papers), Synthesis and biological activity (3 papers) and Protein Degradation and Inhibitors (3 papers). Junyu Xu is often cited by papers focused on Catalytic C–H Functionalization Methods (7 papers), Synthesis and biological activity (3 papers) and Protein Degradation and Inhibitors (3 papers). Junyu Xu collaborates with scholars based in China and United States. Junyu Xu's co-authors include Tao Lu, Ding Du, Weifang Tang, Chao Fang, Yadong Chen, Jing Cao, Hongmei Li, Fei Jiang, Yanmin Zhang and Tao Lu and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

Junyu Xu

21 papers receiving 345 citations

Peers

Countries citing papers authored by Junyu Xu

Since Specialization

Citations

This map shows the geographic impact of Junyu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyu Xu more than expected).

Fields of papers citing papers by Junyu Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyu Xu. The network helps show where Junyu Xu may publish in the future.

Co-authorship network of co-authors of Junyu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Junyu Xu. A scholar is included among the top collaborators of Junyu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyu Xu. Junyu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Macrophage DGKζ-mediated phosphatidic acid remodeling aggravates acute liver failure 2025 ·Acta Pharmaceutica Sinica B ·Yumeng Miao, Tzu-Chun Lin, (unknown), Junyu Xu, (unknown), Zuopeng Li, Xinwen Zhang, (unknown), Tuerganaili Aji, (unknown), Haji Akber Aisa, Jingya Li	1
2	Characterization of substrate distribution and functional implication of lysine acylations in Staphylococcus aureus 2025 ·Journal of Proteomics ·(unknown), (unknown), (unknown), (unknown), (unknown), Tianqi Liu, Shaojie Ma, Bin Liu, Minjia Tan, Junyu Xu	1
3	Recent progress in histone post-translational modifications as regulators of metabolic diseases: A review 2025 ·International Journal of Biological Macromolecules ·Alex Zhu, Tong Ye, Minjia Tan, Junyu Xu	2
4	Metal-Free Cascade Formation of C–C and C–N Bond for the Construction of 3-Cyano-2-Pyridones with Insecticidal Properties 2024 ·Molecules ·(unknown), (unknown), Junyu Xu, Xiaopo Zhang, Youbin Li, Xuesong Wang	2
5	Quercetin Enhances 5-fluorouracil Sensitivity by Regulating the AutophagicFlux and Inducing Drp-1 Mediated Mitochondrial Fragmentation in ColorectalCancer Cells 2024 ·Current Molecular Pharmacology ·Mei Li, (unknown), Min Hu, Junyu Xu, (unknown), Jun Zeng	11
6	A Potential Anti-Glioblastoma Compound LH20 Induces Apoptosis and Arrest of Human Glioblastoma Cells via CDK4/6 Inhibition 2023 ·Molecules ·Yan Wang, Youbin Li, Dong Liu, (unknown), (unknown), Chang Li, (unknown), Yun Wang, Xuesong Wang, Qifu Li, Junyu Xu	3
7	Design, Synthesis, Antitumour Evaluation, and In Silico Studies of Pyrazolo-[1,5-c]quinazolinone Derivatives Targeting Potential Cyclin-Dependent Kinases 2023 ·Molecules ·(unknown), (unknown), (unknown), Dong Liu, Yan Wang, Xuesong Wang, Xueying Zhang, Yinfeng Tan, Yu‐Chen Zhang, Youbin Li, Junyu Xu	5
8	Base‐Promoted Cascade C−N and C−C Formation: An Approach to Pyrido[1,2‐a]pyrimidinones from Ynones and 2‐Methylpyrimidin‐4‐ols 2022 ·Asian Journal of Organic Chemistry ·(unknown), Yinfeng Tan, Yao Tang, Xuemin Cui, Junyu Xu, Youbin Li, Xuesong Wang	1
9	One-Pot Synthesis of α-Ketoamides from α-Keto Acids and Amines Using Ynamides as Coupling Reagents 2022 ·The Journal of Organic Chemistry ·(unknown), Xuemin Cui, Junyu Xu, Yinfeng Tan, Yan Wang, Xuesong Wang, Youbin Li	15
10	Discovery of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as potent and selective CDK9 inhibitors that enable transient target engagement for the treatment of hematologic malignancies 2022 ·European Journal of Medicinal Chemistry ·(unknown), Xiaoyue Liu, Jianhang Huang, (unknown), Hongmei Li, Cong Wang, Qianqian Hong, Lei Yan, (unknown), (unknown), (unknown), Junyu Xu, (unknown), (unknown), Shuwen Li, Tao Lu, Weifang Tang, Yadong Chen	8
11	Discovery of N-(4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-4-(4-methylpiperazin-1-yl)quinazolin-7-amine as a Novel, Potent, and Oral Cyclin-Dependent Kinase Inhibitor against Haematological Malignancies 2021 ·Journal of Medicinal Chemistry ·Jianhang Huang, (unknown), (unknown), Xiaoyue Liu, Hongmei Li, Tianyi Zhang, Junyu Xu, (unknown), Yanmin Zhang, Shaohua Hou, Weifang Tang, Tao Lu, Yadong Chen	12
12	Metal-free cascade synthesis of unsymmetrical 2-aminopyrimidines from imidazolate enaminones 2021 ·RSC Advances ·Xuemin Cui, (unknown), Tingting Zeng, Junyu Xu, Youbin Li, Xuesong Wang	8
13	Aberrant ROS Mediate Cell Cycle and Motility in Colorectal Cancer Cells Through an Oncogenic CXCL14 Signaling Pathway 2021 ·Frontiers in Pharmacology ·Jun Zeng, Mei Li, Junyu Xu, (unknown), Xian Yang, (unknown), Kang Wu, Shuang Chen	17
14	Discovery of coumarin derivatives as potent and selective cyclin-dependent kinase 9 (CDK9) inhibitors with high antitumour activity 2020 ·European Journal of Medicinal Chemistry ·Junyu Xu, Hongmei Li, (unknown), Jianhang Huang, Shuwen Li, (unknown), (unknown), (unknown), (unknown), Fei Jiang, Yanmin Zhang, (unknown), Tianyi Zhang, Yadong Chen, Weifang Tang, Tao Lu	38
15	The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growth 2020 ·Bioorganic & Medicinal Chemistry ·Jianing Song, (unknown), (unknown), (unknown), Junyu Xu, Fei Jiang, (unknown), Shuwen Li, (unknown), Qianqian Gao, Hongmei Li, Yanmin Zhang, Weifang Tang, Tao Lu, Yadong Chen	12
16	Discovery of Benzo[cd]indol-2(1H)-ones and Pyrrolo[4,3,2-de]quinolin-2(1H)-ones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain with Potential High Efficiency against Acute Gouty Arthritis 2019 ·Journal of Medicinal Chemistry ·Fei Jiang, Qinghua Hu, Zhimin Zhang, Hongmei Li, Huili Li, (unknown), Hanwen Li, (unknown), (unknown), Haifang Chen, Yong Cui, Yanle Zhi, Yanmin Zhang, Junyu Xu, Jiapeng Zhu, Tao Lu, Yadong Chen	56
17	Organocatalytic C–C bond activation of cyclopropenones for ring-opening formal [3 + 2] cycloaddition with isatins 2017 ·Organic Chemistry Frontiers ·Junyu Xu, Jing Cao, Chao Fang, Tao Lu, Ding Du	37
18	N -heterocyclic carbene-mediated formal [3+3] annulation of isatin-derived α, β-unsaturated acids: Access to functionalized 3,4′-spirooxindole δ -lactones 2017 ·Tetrahedron ·Weiguo Zhang, Junyu Xu, Jing Cao, Chao Fang, Jindong Zhu, Tao Lu, Ding Du	12
19	Formal [3 + 3] annulation of isatin-derived 2-bromoenals with 1,3-dicarbonyl compounds enabled by Lewis acid/N-heterocyclic carbene cooperative catalysis 2016 ·RSC Advances ·Junyu Xu, Weiguo Zhang, (unknown), (unknown), Ming Liu, (unknown), Siyi Chen, Tao Lu, Ding Du	40
20	N‐Heterocyclic Carbene‐Catalyzed Umpolung Formal [3+3] Cycloaddition of Enals with Isatogens: Access to Fused Indolin‐3‐ones with a Tetrasubstituted Carbon Stereocenter 2015 ·Advanced Synthesis & Catalysis ·Junyu Xu, Shihe Hu, (unknown), Ying Dong, Weifang Tang, Tao Lu, Ding Du	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact